Unknown

Dataset Information

0

Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents.


ABSTRACT: We explored antibody response after first and second BNT162b2 vaccinations, to predict the need for subsequent injections in nursing home (NH) residents. 369 NH residents were tested for IgG against SARS-CoV-2 Receptor-Binding Domain (RBD-IgG) and nucleoprotein-IgG (SARS-CoV-2 IgG II Quant and SARS-CoV-2 IgG Alinity assays, Abbott Diagnostics). In NH residents with prior SARS-CoV-2 infection, the first dose elicited high RBD-IgG levels (≥ 4160 AU/mL) in 99/129 cases (76.9%), with no additional antibody gain after the second dose in 74 cases (74.7%). However, a low RBD-IgG level (< 1050 AU/mL) was observed in 28 (21.7%) residents. The persistence of nucleoprotein-IgG and a longer interval between infection and the first dose were associated with a higher RBD-IgG response (p < 0.0001 and p = 0.0013, respectively). RBD-IgG below 50 AU/mL after the first dose predicted failure to reach the antibody concentration associated with a neutralizing effect after the second dose (≥ 1050 AU/mL). The BNT162b2 vaccine elicited a strong humoral response after the first dose in a majority of NH residents with prior SARS-CoV-2 infection. However, about one quarter of these residents require a second injection. Consideration should be given to immunological monitoring in NH residents to optimize the vaccine response in this vulnerable population.

SUBMITTER: Tuaillon E 

PROVIDER: S-EPMC9373891 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents.

Tuaillon Edouard E   Pisoni Amandine A   Veyrenche Nicolas N   Rafasse Sophia S   Niel Clémence C   Gros Nathalie N   Muriaux Delphine D   Picot Marie-Christine MC   Aouinti Safa S   Van de Perre Philippe P   Bousquet Jean J   Blain Hubert H  

Scientific reports 20220812 1


We explored antibody response after first and second BNT162b2 vaccinations, to predict the need for subsequent injections in nursing home (NH) residents. 369 NH residents were tested for IgG against SARS-CoV-2 Receptor-Binding Domain (RBD-IgG) and nucleoprotein-IgG (SARS-CoV-2 IgG II Quant and SARS-CoV-2 IgG Alinity assays, Abbott Diagnostics). In NH residents with prior SARS-CoV-2 infection, the first dose elicited high RBD-IgG levels (≥ 4160 AU/mL) in 99/129 cases (76.9%), with no additional a  ...[more]

Similar Datasets

| S-EPMC9530588 | biostudies-literature
| S-EPMC9115082 | biostudies-literature
| S-EPMC8589355 | biostudies-literature
| S-EPMC8923035 | biostudies-literature
| S-EPMC5751715 | biostudies-literature
| S-EPMC4762025 | biostudies-literature
| S-EPMC8242857 | biostudies-literature
| PRJEB31196 | ENA
| S-EPMC11359559 | biostudies-literature